Literature DB >> 2583283

Testing topological models for the membrane penetration of the fusion peptide of influenza virus hemagglutinin.

J Brunner1.   

Abstract

Low pH-induced binding of the bromelain-solubilized form of influenza virus hemagglutinin (BHA) to membranes occurs through the fusion peptide. From asymmetric hydrophobic photolabeling of membranes, evidence was obtained that this peptide penetrates only one leaflet of the bilayer. The asymmetrical labeling was achieved by employing a photoreactive analogue of a fatty acid whose transbilayer distribution can be manipulated by a membrane proton gradient.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2583283     DOI: 10.1016/0014-5793(89)81574-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  Intermediates in influenza induced membrane fusion.

Authors:  T Stegmann; J M White; A Helenius
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

2.  Structural features of membrane fusion between influenza virus and liposome as revealed by quick-freezing electron microscopy.

Authors:  T Kanaseki; K Kawasaki; M Murata; Y Ikeuchi; S Ohnishi
Journal:  J Cell Biol       Date:  1997-06-02       Impact factor: 10.539

3.  Influenza hemagglutinin assumes a tilted conformation during membrane fusion as determined by attenuated total reflection FTIR spectroscopy.

Authors:  S A Tatulian; P Hinterdorfer; G Baber; L K Tamm
Journal:  EMBO J       Date:  1995-11-15       Impact factor: 11.598

Review 4.  The three lives of viral fusion peptides.

Authors:  Beatriz Apellániz; Nerea Huarte; Eneko Largo; José L Nieva
Journal:  Chem Phys Lipids       Date:  2014-04-02       Impact factor: 3.329

5.  Plasticity of influenza haemagglutinin fusion peptides and their interaction with lipid bilayers.

Authors:  Loredana Vaccaro; Karen J Cross; Jens Kleinjung; Suzana K Straus; David J Thomas; Stephen A Wharton; John J Skehel; Franca Fraternali
Journal:  Biophys J       Date:  2004-10-08       Impact factor: 4.033

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.